JHS Svendgaard Laboratories Limited

BSE: 532771 NSE: JHS
JHS Svendgaard Laboratories Limited - fmcg in Nahan, Himachal Pradesh, India. FY 2026 financials & compliance.
CIN L74110HP2004PLC027558 Incorporated 08 October 2004 ROC Himachal Pradesh HQ Nahan, Himachal Pradesh, India
Active Listed - NSE: JHS · BSE: 532771 Public Limited Company FMCG
Data last updated
Market Cap
₹71.50 Cr
JHS · NSE
Share Price
₹7.93
-3.06% today
Revenue
₹102 Cr
FY 2025-26 · +10.5% YoY
EBITDA
₹2.61 Cr
Margin 2.6%
Net Profit
−₹1.93 Cr
FY 2025-26 · +89.6% YoY
Authorised capital
₹101 Cr
Registered with MCA
Paid-up capital
₹87.41 Cr
Issued & subscribed
Open charges
₹21.01 Cr
Satisfied ₹203.84 Cr

About JHS Svendgaard Laboratories Limited

Data last updated:

JHS Svendgaard Laboratories Limited is a public limited company based in Nahan, Himachal Pradesh, India. It operates in the personal care and skincare products segment of the FMCG sector. It was incorporated on 08 October 2004 and has been in existence for over 22 years.

The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN L74110HP2004PLC027558. Its GSTIN is 02AABCJ5766G1ZP (Himachal Pradesh). The company holds 11 GST registrations, of which 8 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 532771 and NSE: JHS.

The company has an authorised share capital of ₹101 Cr and a paid-up capital of ₹87.41 Cr. It is led by directors including Nikhil Nanda (Managing Director) and Rajagopal Chakravarthi Venkateish.

Its last annual general meeting (AGM) was held on 20 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Trilokpur Roadkala Amb Distt Sirmaur, Nahan, Himachal Pradesh, India – 173030.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹101.69 Cr, a growth of 10.5% compared to the previous year. For the same year it recorded a net loss of ₹1.93 Cr (net margin -1.9%) and EBITDA of ₹2.61 Cr (EBITDA margin 2.6%). The net worth stands at ₹174.67 Cr (up 1.1% YoY). Total assets are valued at ₹191.94 Cr (up 5.6% YoY).

The company has about 240 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.

The company is associated with 1 brand: Svendgaard. As per MCA filings, the company has open charges of ₹21.01 Cr and satisfied charges of ₹203.84 Cr on record. Court records list 78 cases involving the company, including 61 filed by the company and 17 filed against it; 13 cases are pending. The company has 104 deals on record (76 market trades, 11 secondary share transfers, 10 rights issues), with disclosed funding of ₹46.6 Cr; the latest was in September 2025. Its 3 peer companies in the FMCG industry (Personal Care and Skin Care), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger; the largest is Eight Brothers Sales Private Limited with revenue of ₹75.81 Cr. The company has 10 MSME Form 1 returns on record between 2019 and 2022, listing 1,175 overdue payments to 71 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website svendgaard.com.

Company details

CIN L74110HP2004PLC027558
Registration Number 027558
Incorporation Date 08 October 2004
ROC Himachal Pradesh
Listing Status Listed - Listed on NSE (JHS); Listed on BSE (532771)
Company Status Active
Date of Last AGM 20 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant

CIN history

JHS Svendgaard Laboratories has one previous CIN (Corporate Identification Number): L24230HP2004PLC027558. The current CIN is L74110HP2004PLC027558, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L74110HP2004PLC027558Current
L24230HP2004PLC027558Previous
Key People
Nikhil Nanda Managing Director Rajagopal Chakravarthi Venkateish Director Kapil Minocha Director

Contact details

JHS Svendgaard Laboratories Limited's registered office is in Nahan, Himachal Pradesh. Its website is svendgaard.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    svendgaard.com
  • Social Media
  • Registered Address
    Trilokpur Roadkala Amb Distt Sirmaur, Nahan, Himachal Pradesh, India – 173030
  • Industry
    FMCG, Personal Care & Skincare Products

To see the full contact details of JHS Svendgaard Laboratories Limited, buy the company report.

Comprehensive company report
JHS Svendgaard Laboratories Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

JHS Svendgaard Laboratories operates one associated brand: Svendgaard. Each brand links to its own profile.

BrandDescriptionWebsite
Svendgaard
Svendgaard is recognized as a leading FMCG and oral care products manufacturer.svendgaard.com

Business activity

The main business activity of JHS Svendgaard Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of JHS Svendgaard Laboratories Limited, buy the company report.

Financials of JHS Svendgaard Laboratories Limited

FY 2025-26 filings available

JHS Svendgaard Laboratories Limited reported revenue of ₹101.69 Cr (up 10.5% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹102 Cr
+10.5% YoY
EBITDA
₹2.61 Cr
+138.0% YoY
Profit After Tax
−₹1.93 Cr
+89.6% YoY
Net Worth
₹175 Cr
+1.1% YoY
Total Assets
₹192 Cr
+5.6% YoY
Total Debt
₹14.85 Cr
+129.9% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue10292.0070.8084.8186.25101139
Revenue growth+10.5%+29.9%-16.5%-1.7%-14.4%-27.6%-
EBITDA2.61(6.86)(0.93)(27.71)(0.85)1.92(8.97)
EBITDA margin+2.6%-7.5%-1.3%-32.7%-1.0%+1.9%-6.5%
Profit before tax(2.30)(12.50)(3.43)(22.96)0.100.97(5.84)
Net profit(1.93)(18.57)(4.06)22.59(3.55)1.216.79
Net profit margin-1.9%-20.2%-5.7%+26.6%-4.1%+1.2%+4.9%
EPS (₹)(0.22)(2.31)(0.52)0.52(0.62)0.19(0.32)
Balance sheet
Total assets192182178192204206194
Net worth175173170174186189178
Total debt14.856.465.132.586.197.018.58
Cash & bank19.1019.5410.3638.656.4621.150.93
Net working capital40.1533.9024.2948.6458.7397.2877.69
Cash flow
Cash from operations(2.66)(5.18)(9.18)23.29(9.14)12.0310.35
Cash from investing(11.68)(20.25)(21.14)9.68(4.70)(2.23)(10.97)
Cash from financing11.3423.072.17(0.64)(1.67)10.310.49
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue30.3832.7023.2722.2823.4525.1722.6619.68
Revenue growth (YoY)+29.6%+29.9%+2.7%+13.2%-4.2%---
Other income0.090.730.591.141.001.420.270.86
EBITDA2.07(1.62)1.680.911.66(8.24)0.25(0.85)
EBITDA margin+6.8%-5.0%+7.2%+4.1%+7.1%-32.7%+1.1%-4.3%
Depreciation1.821.861.901.861.882.021.971.98
Interest0.280.220.280.200.160.210.130.11
Profit before tax0.06(2.97)0.09(0.01)0.62(9.05)(1.58)(2.08)
Tax(1.03)0.59(0.71)0.18(0.43)(2.09)0.258.24
Net profit1.09(3.56)0.80(0.19)1.05(6.96)(1.83)(10.32)
EPS (₹)0.12(0.42)0.09(0.02)0.12(0.84)(0.21)(1.24)
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue10292.0070.8084.8179.9196.96133
Revenue growth+10.5%+29.9%-16.5%+6.1%-17.6%-27.1%-
EBITDA2.62(6.86)(0.92)(27.71)0.183.66(1.16)
EBITDA margin+2.6%-7.5%-1.3%-32.7%+0.2%+3.8%-0.9%
Profit before tax(2.29)(12.50)(3.42)(22.96)1.923.201.80
Net profit(1.92)(18.57)(4.05)1.02(2.44)2.7210.63
Net profit margin-1.9%-20.2%-5.7%+1.2%-3.1%+2.8%+8.0%
EPS (₹)(0.22)(2.31)(0.52)(2.23)(0.38)0.430.29
Balance sheet
Total assets192182178179195195185
Net worth175173170174190191182
Total debt14.856.465.132.582.172.472.56
Cash & bank19.0819.5210.1338.625.4816.880.51
Net working capital40.1433.8824.0648.9168.5082.2468.73
Cash flow
Cash from operations(2.65)(4.96)(8.70)23.25(11.28)15.4215.14
Cash from investing(11.68)(20.25)(21.83)9.68(0.96)(5.58)(6.76)
Cash from financing11.3423.072.17(0.90)0.026.42(8.45)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue30.3832.7023.2722.2823.4525.1722.6619.68
Revenue growth (YoY)+29.6%+29.9%+2.7%+13.2%-4.2%---
Other income0.090.730.591.141.001.420.270.86
Total expenses28.3134.3221.5921.3721.7933.4122.4120.53
EBITDA2.07(1.62)1.680.911.66(8.24)0.25(0.85)
EBITDA margin+6.8%-5.0%+7.2%+4.1%+7.1%-32.7%+1.1%-4.3%
Depreciation1.821.861.901.861.882.021.971.98
Interest0.280.220.280.200.160.210.130.11
Profit before tax0.06(2.97)0.09(0.01)0.62(9.05)(1.58)(2.08)
Tax(1.03)0.59(0.71)0.18(0.43)(2.09)0.258.24

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 27 Oct 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue30.3832.7023.2722.2823.4525.1722.6619.68
Revenue growth (YoY)+29.6%+29.9%+2.7%+13.2%-4.2%---
Other income0.090.730.591.141.001.420.270.86
EBITDA2.07(1.62)1.680.911.66(8.24)0.25(0.85)
EBITDA margin+6.8%-5.0%+7.2%+4.1%+7.1%-32.7%+1.1%-4.3%
Depreciation1.821.861.901.861.882.021.971.98
Interest0.280.220.280.200.160.210.130.11
Profit before tax0.06(2.97)0.09(0.01)0.62(9.05)(1.58)(2.08)
Tax(1.03)0.59(0.71)0.18(0.43)(2.09)0.258.24
Net profit1.09(3.56)0.80(0.19)1.05(6.96)(1.83)(10.32)
EPS (₹)0.12(0.42)0.09(0.02)0.12(0.84)(0.21)(1.24)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue10292.0070.8084.8186.25101139
Revenue growth+10.5%+29.9%-16.5%-1.7%-14.4%-27.6%-
Other income3.452.884.3111.329.397.5413.84
Total expenses99.0898.8671.7311387.1098.85148
Employee cost0.0010.129.2110.1911.4510.0813.44
EBITDA2.61(6.86)(0.93)(27.71)(0.85)1.92(8.97)
EBITDA margin+2.6%-7.5%-1.3%-32.7%-1.0%+1.9%-6.5%
Depreciation7.507.956.356.027.057.258.76
Interest0.860.570.460.551.391.241.95
Profit before tax(2.30)(12.50)(3.43)(22.96)0.100.97(5.84)
Tax(0.37)7.240.63(5.43)4.40(0.38)(0.99)
Net profit(1.93)(18.57)(4.06)22.59(3.55)1.216.79
Net profit margin-1.9%-20.2%-5.7%+26.6%-4.1%+1.2%+4.9%
EPS (₹)(0.22)(2.31)(0.52)0.52(0.62)0.19(0.32)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital87.4185.6078.4078.4064.9064.4060.90
Reserves & surplus87.2684.6291.4995.44121124117
Shareholders' funds (net worth)175173170174186189178
Minority interest0.000.000.000.009.149.276.60
Secured loans13.275.143.560.380.690.740.74
Unsecured loans1.581.321.572.205.506.277.84
Total debt14.856.465.132.586.197.018.58
Total liabilities192182178192204206194
Assets
Gross block13913313310290.2492.3087.05
Net block89.3090.3390.4165.0758.5263.2265.64
Capital work in progress3.980.000.828.5719.968.927.05
Investments5.103.643.452.973.622.056.03
Inventories15.9814.5112.6613.0112.2112.116.15
Sundry debtors16.7613.0612.8818.5418.1258.7196.15
Cash & bank balances19.1019.5410.3638.656.4621.150.93
Loans & advances12.408.897.7714.6539.8327.4121.51
Total current assets64.2456.0043.6784.8576.62119125
Total current liabilities24.0922.1019.3836.2117.8922.1047.05
Net working capital40.1533.9024.2948.6458.7397.2877.69
Total assets192182178192204206194
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash6.759.1037.255.1920.790.680.81
Net cash from operating activities(2.66)(5.18)(9.18)23.29(9.14)12.0310.35
Net cash from investing activities(11.68)(20.25)(21.14)9.68(4.70)(2.23)(10.97)
Net cash from financing activities11.3423.072.17(0.64)(1.67)10.310.49
Net change in cash(2.99)(2.36)(28.14)32.33(15.50)20.11(0.13)
Closing cash19.1019.5410.3638.656.4621.150.93
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+10.5%+29.9%-16.5%-1.7%-14.4%-27.6%-
EBITDA growth+138.1%-637.6%+96.6%-3160.0%-144.3%+121.4%-
PBT growth+81.6%-264.4%+85.1%--89.7%+9998.0%-184.9%
Net income growth+89.6%-357.4%-118.0%+736.3%-393.4%-82.2%-
Revenue CAGR (3Y)+6.2%+2.2%-11.1%-15.2%-11.4%-10.4%+9.8%
EBITDA CAGR (3Y)-+100.6%-+45.6%+12.9%-48.1%-
Profitability & leverage
Net income margin-1.9%-21.5%-5.7%-20.7%-5.0%+1.3%-3.5%
Return on capital employed-0.0%0.0%0.0%+0.8%+1.1%+3.6%
Return on net worth-0.0%0.0%0.0%-2.0%+0.7%+2.2%
Debt / equity-0.030.020.020.040.040.04
Long-term debt / equity-0.010.010.020.030.030.02
Interest cover-17.59-3.85-6.32-1.63-17.59-23.26-11.00
Efficiency & per share
Fixed asset turnover-0.690.600.880.951.121.57
Inventory turnover-6.775.526.737.0911.0416.81
Debtors turnover-7.094.514.632.251.301.86
EPS (₹)(0.22)(2.31)(0.52)0.52(0.62)0.19(0.32)
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)0.0019.8921.6722.1728.6429.2629.23
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue30.3832.7023.2722.2823.4525.1722.6619.68
Revenue growth (YoY)+29.6%+29.9%+2.7%+13.2%-4.2%---
Other income0.090.730.591.141.001.420.270.86
Total expenses28.3134.3221.5921.3721.7933.4122.4120.53
EBITDA2.07(1.62)1.680.911.66(8.24)0.25(0.85)
EBITDA margin+6.8%-5.0%+7.2%+4.1%+7.1%-32.7%+1.1%-4.3%
Depreciation1.821.861.901.861.882.021.971.98
Interest0.280.220.280.200.160.210.130.11
Profit before tax0.06(2.97)0.09(0.01)0.62(9.05)(1.58)(2.08)
Tax(1.03)0.59(0.71)0.18(0.43)(2.09)0.258.24
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue10292.0070.8084.8179.9196.96133
Revenue growth+10.5%+29.9%-16.5%+6.1%-17.6%-27.1%-
Other income3.452.884.3111.328.145.5511.75
Total expenses99.0798.8671.7211379.7393.30134
Employee cost0.0010.129.2110.199.938.388.75
EBITDA2.62(6.86)(0.92)(27.71)0.183.66(1.16)
EBITDA margin+2.6%-7.5%-1.3%-32.7%+0.2%+3.8%-0.9%
Depreciation7.507.956.356.025.905.567.43
Interest0.860.570.460.550.500.451.36
Profit before tax(2.29)(12.50)(3.42)(22.96)1.923.201.80
Tax(0.37)7.240.63(5.43)4.370.430.02
Net profit(1.92)(18.57)(4.05)1.02(2.44)2.7210.63
Net profit margin-1.9%-20.2%-5.7%+1.2%-3.1%+2.8%+8.0%
EPS (₹)(0.22)(2.31)(0.52)(2.23)(0.38)0.430.29
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital87.4185.6078.4078.4064.9064.4060.90
Reserves & surplus87.6785.0391.8995.84125127121
Shareholders' funds (net worth)175173170174190191182
Secured loans14.815.143.560.380.370.330.66
Unsecured loans0.041.321.572.201.802.141.90
Total debt14.856.465.132.582.172.472.56
Total liabilities192182178179195195185
Assets
Gross block13913313310186.1084.0077.56
Net block89.3090.3390.4165.0655.4058.6857.83
Capital work in progress3.980.000.828.5715.838.856.98
Investments5.113.653.462.9815.3914.2116.52
Inventories15.9814.5112.6613.019.259.193.65
Sundry debtors16.7613.0612.8818.5416.1958.6995.31
Cash & bank balances19.0819.5210.1338.625.4816.880.51
Loans & advances12.418.897.7714.7353.9117.1913.73
Total current assets64.2355.9843.4484.9084.83102113
Total current liabilities24.0922.1019.3835.9916.3319.7144.47
Net working capital40.1433.8824.0648.9168.5082.2468.73
Total assets192182178179195195185
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash6.728.8737.225.1816.530.270.34
Net cash from operating activities(2.65)(4.96)(8.70)23.25(11.28)15.4215.14
Net cash from investing activities(11.68)(20.25)(21.83)9.68(0.96)(5.58)(6.76)
Net cash from financing activities11.3423.072.17(0.90)0.026.42(8.45)
Net change in cash(2.99)(2.14)(28.35)32.03(12.22)16.26(0.07)
Closing cash19.0819.5210.1338.625.4816.880.51
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+10.5%+29.9%-16.5%+6.1%-17.6%-27.1%-
EBITDA growth+138.2%-645.7%+96.7%--95.1%+415.5%-
PBT growth+81.7%-265.5%+85.1%--40.0%+77.8%-65.5%
Net income growth+89.7%-358.5%-497.1%+141.8%-189.7%-74.4%-
Revenue CAGR (3Y)+6.2%+4.8%-10.0%-13.9%-12.6%-11.2%+8.2%
EBITDA CAGR (3Y)---+188.0%-71.1%-39.4%-
Profitability & leverage
Net income margin-1.9%-21.5%-5.7%-20.7%-3.1%+2.9%+1.3%
Return on capital employed-0.0%0.0%0.0%+1.3%+1.9%+7.4%
Return on net worth-0.0%0.0%0.0%-1.3%+1.5%+5.9%
Debt / equity-0.030.020.010.010.010.03
Long-term debt / equity-0.010.010.010.010.010.01
Interest cover-17.62-3.85-6.33-1.63-8.74-23.68-15.83
Efficiency & per share
Fixed asset turnover-0.690.600.900.941.201.60
Inventory turnover-6.775.527.628.6715.1021.85
Debtors turnover-7.094.514.882.131.261.76
EPS (₹)(0.22)(2.31)(0.52)(2.23)(0.38)0.430.29
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)0.0019.9321.7222.2229.2429.6929.80

To see the full year-wise statements and ratios of JHS Svendgaard Laboratories Limited, buy the company report.

Board of directors of JHS Svendgaard Laboratories Limited

JHS Svendgaard Laboratories has 6 current directors and 38 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajagopal Chakravarthi Venkateish
Also directs: Lex Sportel Vision Private Limited, Lex Entertainment and Media Private Limited
Director23 Jun 20206 Years 4 MonthsCurrent
Kapil Minocha
Also directs: Karan Out of Box Private Limited
Director23 Jun 20206 Years 4 MonthsCurrent
Vinay MittalDirector27 May 20224 Years 5 MonthsCurrent
Nikhil Nanda
Also directs: Maya Brands LLP, Starpool Consultants & Advisors LLP, Nirvikar Films LLP and 3 more
Managing Director08 Oct 200422 Years 0 MonthsCurrent
Paramvir Singh
Also directs: Magna Waves Buildtech Private Limited
Director13 Nov 20241 Years 11 MonthsCurrent
Upma ChawdhryDirector14 Aug 20233 Years 2 MonthsCurrent
View all directors

Peer comparison

JHS Svendgaard Laboratories Limited is compared with the 3 companies closest to it by revenue in the FMCG industry (Personal Care and Skin Care), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
JHS Svendgaard Laboratories Limitedthis company₹101.69 Cr (FY 2026)-₹1.93 Cr-1.9%10.5%240Nahan, Himachal Pradesh, India
Eight Brothers Sales Private Limited₹75.81 Cr (FY 2024)-11.0%Jaipur, Rajasthan, India
Wipro Consumer and Personal Care Private Limited₹75.69 Cr (FY 2025)28.0%Bangalore, Karnataka, India
Sprivil Healthcare Private Limited₹75.32 Cr (FY 2025)55.0%Satara, Maharashtra, India

To see the full peer comparison of JHS Svendgaard Laboratories Limited, buy the company report.

Auditor

JHS Svendgaard Laboratories Limited is audited by TATTVAM AND CO for the financial year 2024.

Auditor firmFinancial yearFirm registration number
TATTVAM AND COFY 2024015048N

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 33.80%, foreign institutional investors hold 3.10%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 63.10%.

Promoters: 33.80%FII (Foreign Institutional): 3.10%Retail & Others: 63.10%
Sep 2026
QUARTER
33.80% Promoters
3.10% FII (Foreign Institutional)
63.10% Retail & Others
Promoter holding - history
Now 33.80% · Sep 2026High 34.60% · Dec 2025Low 33.80% · Jun 2026
32%33%34%35%36%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 34.60%Mar 2026: 34.60%Jun 2026: 33.80%Sep 2026: 33.80%34.60%33.80%33.80%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters33.80%33.80%34.60%34.60%
Public66.20%66.20%65.40%65.40%

Charges & borrowings

Open charges
₹21.01 Cr
Satisfied charges
₹203.84 Cr
Breakdown by lending institutions
Sidbi₹19.15 Cr
Hdfc Bank Limited₹0.92 Cr
Others₹0.64 Cr
Commissioner of Industries Himachal Pradesh Member Secretary Single Window Clearance Agency₹0.30 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
10 Apr 2026101298341Hdfc Bank Limited₹16.85 LakhOpen
21 Mar 2026101277971Others₹64 LakhOpen
24 Mar 2025101083232Sidbi₹3 CrOpen
09 Jan 2025101066364Hdfc Bank Limited₹23.49 LakhOpen
06 Jan 2025101040955Sidbi₹2 CrOpen

To see the full charge records of JHS Svendgaard Laboratories Limited, buy the company report.

Total charge records: 36 View all charges

Deals & funding

JHS Svendgaard Laboratories Limited has 104 deals on record (76 market trades, 11 secondary share transfers, 10 rights issues), with disclosed funding of ₹46.6 Cr; the latest was in September 2025.

Total deals
104
Market trades
76
Secondary share transfers
11
Rights issues
10
Funding rounds
6
Disclosed funding
₹46.6 Cr

Deals on record (5 of 104)

WhenDealAmountParties
Sep 2025Market trade₹71.2 LakhBuyer: an individual
Seller: Green Portfolio Private Limited
Jul 2024Market trade₹1.04 CrSeller: Zaveri Finstock Private Limited
Jul 2024Market trade₹1.13 CrSeller: Zaveri Finstock Private Limited
Jun 2020Market trade₹46.2 LakhSeller: HT Media Limited
Jun 2020Market trade₹52 LakhSeller: HT Media Limited

To see the full deal history of JHS Svendgaard Laboratories Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

JHS Svendgaard Laboratories Limited has 10 MSME Form 1 returns on record between 2019 and 2022, listing 1,175 overdue payments to 71 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 71)

SupplierAmount dueDue sinceReported on
Premier Paper Packaging Private Limited
HBD Packaging Private Limited
Himachal Polyolefins Limited
Jasmer Pack Limited
Alok Industries Rajsthan

To see the full MSME payment records of JHS Svendgaard Laboratories Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

JHS Svendgaard Laboratories has 1 subsidiary company. This group structure data is as of FY 2025. The table lists each entity with its relationship and holding.

1
Subsidiary companies
Key subsidiaries
Company NameCINShares held
JHS Svendgaard Mechanical and Warehouse Private LimitedU29199DL2007PTC159125

To see the full group structure of JHS Svendgaard Laboratories Limited, buy the company report.

Employees & EPFO

JHS Svendgaard Laboratories Limited has a workforce of 240 employees on its EPFO records as of Sep 23, 2025, across 3 active EPFO establishments.

Employee count
240
Active EPFO establishments
3
Employee growth
-15.19%

GST

JHS Svendgaard Laboratories has 11 GST registrations: 8 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
11
Active
8
Cancelled / inactive
3
GSTINStateStatusRegistered on
02AABCJ5766G1ZPHimachal PradeshActive01 Jul 2017
02AABCJ5766G2ZOHimachal PradeshActive27 Feb 2019
07AABCJ5766G3ZDDelhiActive21 Jul 2017
19AABCJ5766G2Z9West BengalActive29 Jan 2024

To see the full GST registrations and return filing status of JHS Svendgaard Laboratories Limited, buy the company report.

Recent activity

JHS Svendgaard Laboratories Limited has 64 board changes on record since 2004: 36 appointments and 28 cessations. The latest: Mukul Pathak ceased to be Director on 02 Jul 2025.

Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.17 Cr with Charge ID 101298341 was registered on 10 Apr 2026.
Filing
Jhs Svendgaard Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Himachal Pradesh.
Charges
A charge with Others amounted to Rs. 0.64 Cr with Charge ID 101277971 was registered on 21 Mar 2026.
Charges
A charge registered on 30 Nov 2018 via Charge ID 100243886 with Others was fully satisfied on 21 Nov 2025.
AGM
Jhs Svendgaard Laboratories Limited last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records.
Ceased
Mukul Pathak ceased to be Director.
Charges
A charge with Sidbi amounted to Rs. 3.00 Cr with Charge ID 101083232 was registered on 24 Mar 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.23 Cr with Charge ID 101066364 was registered on 09 Jan 2025.
Charges
A charge with Sidbi amounted to Rs. 2.00 Cr with Charge ID 101040955 was registered on 06 Jan 2025.
Charges
A charge registered on 12 Feb 2024 via Charge ID 100874351 with Indian Bank was fully satisfied on 12 Dec 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.29 Cr with Charge ID 101033576 was registered on 27 Nov 2024.
Charges
A charge with Sidbi amounted to Rs. 8.00 Cr with Charge ID 101013571 was registered on 18 Nov 2024.

126 earlier events are in the company report.

News

Frequently asked questions

JHS Svendgaard Laboratories is an active public limited company based in Nahan, Himachal Pradesh, India. The company works in personal care and skincare products, within the FMCG industry. It was incorporated on 08 October 2004 (22+ years old) and is registered under CIN L74110HP2004PLC027558. Listed on BSE: 532771 and NSE: JHS.

JHS Svendgaard Laboratories reported revenue of ₹101.69 Cr for FY 2025-26 (up 10.5% YoY) based on consolidated financials.

JHS Svendgaard Laboratories has 6 current directors:

The latest financial statements of JHS Svendgaard Laboratories on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 20 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of JHS Svendgaard Laboratories is 02AABCJ5766G1ZP, registered in Himachal Pradesh. The company has 11 GST registrations in all, of which 8 are active and 3 are cancelled or inactive. Other active GSTINs include 02AABCJ5766G2ZO (Himachal Pradesh), 07AABCJ5766G3ZD (Delhi), 19AABCJ5766G2Z9 (West Bengal).

The CIN (Corporate Identification Number) of JHS Svendgaard Laboratories is L74110HP2004PLC027558. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. JHS Svendgaard Laboratories is a listed company as per MCA records. Its shares are listed on both BSE (code: 532771) and NSE (symbol: JHS).

JHS Svendgaard Laboratories has 78 court cases on record: 61 filed by the company and 17 filed against it. 13 are pending. Most are in the high courts.

JHS Svendgaard Laboratories was incorporated on 08 October 2004, making it 22+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.

JHS Svendgaard Laboratories has 104 deals on record (76 market trades, 11 secondary share transfers, 10 rights issues), with disclosed funding of ₹46.6 Cr; the latest was in September 2025.

The peers of JHS Svendgaard Laboratories by revenue are Eight Brothers Sales Private Limited, Wipro Consumer and Personal Care Private Limited, Sprivil Healthcare Private Limited, all in the FMCG industry (Personal Care and Skin Care), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Mukul Pathak ceased to be Director on 02 Jul 2025. Paramvir Singh was appointed as Director on 13 Nov 2024. Deepesh Sharma ceased to be CFO on 16 Oct 2023. JHS Svendgaard Laboratories has 64 board changes on record in total.